Point of Care Testing to Improve Monitoring of LVAD Patients
NCT03555552 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2023-08-09
Summary
The purpose of this study is to develop and validate the accuracy of a low-cost "point-of-care" test (POCT) that allows monitoring of markers for anticoagulation and thrombosis (local coagulation or clotting of the blood), to be used by patients with advanced heart failure (AHF) on left ventricular assist device (LVAD) support. The investigators central hypothesis is that the fully-printed AT-POCT utilizing low-cost (printed) cassettes and detector will produce an inexpensive and convenient option for daily self-monitoring of PT/INR and LDH over existing methods.
Conditions
- Anticoagulation and Thrombosis Point of Care Test (AT-POCT)
Interventions
- DEVICE
-
Anticoagulation and Thrombosis Point of Care Test(AT-POCT)
Capillary action automatically draws blood into the channel containing printed assay reagents which solubilize upon contact with blood and react with analytes of interest.
- DEVICE
-
Duke Central Automated Laboratory (DCAL)
DCAL measurement of INR will occur by an ACL TOP 750 Analyzer (IL Inc.), and LDH by standard enzymatic activity assay will be run on the automated Beckman DxC800.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Ashutosh Chilkoti, PhD · Duke University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-01
- Primary Completion
- 2024-07-30
- Completion
- 2024-08-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Benefit of Machine Learning to Diagnose Deep Vein Thrombosis Compared to Gold Standard Ultrasound
NCT05288413 ·Status: WITHDRAWN
-
Symptom-driven Referral for Evaluation of Chronic Thromboembolic Disease or Pulmonary Hypertension in Patients With Previous Acute Pulmonary Embolism
NCT03729492 ·Status: UNKNOWN ·Phase: NA
-
Safety of a Diagnostic Strategy With D-Dimer Testing for PE
NCT00182221 ·Status: COMPLETED ·Phase: PHASE3
-
Non-invasive Diagnosis of Pulmonary Embolism by Use of Biomarkers in Exhaled Breath
NCT06135220 ·Status: COMPLETED
-
Study of Diagnosis and Pathophysiology of Pulmonary Embolism (APE 1 Trial)
NCT00302601 ·Status: TERMINATED ·Phase: NA
-
Two-Site Compression POINt-OF-CARE Ultrasonography for DVT
NCT03056196 ·Status: UNKNOWN
-
Standard vs Ultrasound-assisted Catheter Thrombolysis for Submassive Pulmonary Embolism
NCT03086317 ·Status: COMPLETED ·Phase: NA
-
Assessment of Blood Coagulation Disorders in Patients With Pulmonary Hypertension
NCT03195543 ·Status: UNKNOWN
-
Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events
NCT03183063 ·Status: COMPLETED ·Phase: NA
-
Hemopatch Performance Evaluation: A Prospective Observational Registry
NCT03392662 ·Status: COMPLETED
-
Age-adjusted D-dimer Cut-off Levels to Rule Out Pulmonary Embolism
NCT01134068 ·Status: COMPLETED ·Phase: PHASE4
-
CTEPH Identification an Standard Computerised Tomography Pulmonary Angiography in Pulmonary Embolism Patients
NCT03083093 ·Status: COMPLETED
-
Evaluation of Latent Pulmonary Arterial Hypertension in Congenital Shunt Lesions
NCT02552485 ·Status: COMPLETED
-
Non-invasive Diagnosis of Pulmonary Embolism by Use of Biomarkers in Exhaled Breath Condensate
NCT04010760 ·Status: COMPLETED
-
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography
NCT01607489 ·Status: COMPLETED ·Phase: NA
-
Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension
NCT03388476 ·Status: ENROLLING_BY_INVITATION
-
Differential Diagnosis of Pulmonary Hypertension With Automated Image Analysis
NCT04329312 ·Status: TERMINATED
-
Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong
NCT07029841 ·Status: RECRUITING
-
Short-term Clinical Deterioration After Acute Pulmonary Embolism
NCT03915925 ·Status: COMPLETED
-
Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform
NCT04927156 ·Status: RECRUITING
-
Venous Phase Dual Energy CT in Patients Suspected for Pulmonary Embolism.
NCT04859478 ·Status: UNKNOWN ·Phase: NA
-
Catheter Directed Therapy in Intermediate Risk Pulmonary Embolism Patients
NCT05612854 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions
NCT03773159 ·Status: RECRUITING
-
Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients
NCT01415869 ·Status: COMPLETED
-
Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism
NCT02396758 ·Status: COMPLETED ·Phase: PHASE4